Doubts over self-testing in diabetes

Patients with type 2 diabetes should not routinely monitor their own blood glucose, experts say, after research confirmed the approach confers only minor benefit for those not taking insulin.

A meta-analysis last week reported that while self-monitoring did lead to significant HbA1C reductions in non-insulin treated patients, these reductions were too small to be clinically relevant.

Over six months, self-monitoring led to just a 0.25% drop in HbA1C